Insulin Glargine Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Oct 24, 2025 · last update Oct 24, 2025
Manufacturers: Eli Lilly and Co.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Basaglar, Injection, U-100 Tempo Pen (NDC 0002-8214-05) | Eli Lilly and Co. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Oct 24, 2025 Updated Oct 24, 2025 Discontinued Oct 24, 2025 |